* Triangle Pharmaceuticals Inc., of Durham, N.C., said theunderwriters of the company's recent initial public offering haveexercised their over-allotment option by purchasing 332,652 sharesof common stock from the company at $10 a share. As a result, thecompany raised an additional $3,326,520 in gross proceeds.
* Viragen Ltd., of Miami, said the company's common stock hasbeen approved for listing on the NASDAQ SmallCap Market.Trading began Dec. 5 under the symbol "VERP."
* XOMA Corp., of Berkeley, Calif., is presenting data from thecompany's recently completed Phase I/II clinical study, testing itsproduct Neuprex as a treatment for severe pediatricmeningococcemia, an often deadly infection that primarily attackschildren.
(c) 1997 American Health Consultants. All rights reserved.